![Ben Vollrath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Vollrath
Operationeel Directeur bij Amprion, Inc.
Actieve functies van Ben Vollrath
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Operationeel Directeur | - | - |
Loopbaan van Ben Vollrath
Eerdere bekende functies van Ben Vollrath
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Avalon Ventures Management LLC
![]() Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | Private Equity Investor | 01-02-2007 | 31-12-2009 |
Orphagen Pharmaceuticals
![]() Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | 31-01-2007 |
Afraxis, Inc.
![]() Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Oprichter | 01-01-2007 | - |
Renovis, Inc.
![]() Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Corporate Officer/Principal | - | - |
Opleiding van Ben Vollrath
Ruprecht-Karls-Universität Heidelberg | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Duitsland | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Private Equity Investor | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Avalon Ventures Management LLC
![]() Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | Finance |
Orphagen Pharmaceuticals
![]() Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Health Technology |
Renovis, Inc.
![]() Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Afraxis, Inc.
![]() Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Health Technology |
Amprion, Inc.
![]() Amprion, Inc. Medical SpecialtiesHealth Technology Amprion, Inc. is a company based in San Diego, CA that specializes in biomarker testing for brain diseases. The American company's Syntap® biomarker test aids physicians in the clinical diagnosis of Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The test identifies misfolded synuclein aggregates, a hallmark in various neurodegenerative diseases. Amprion plans to launch other biomarker tests to detect Alzheimer's in early stages. The company was founded in 2006 by Claudio Soto and Russ M. Lebovitz, who has been the CEO since then. | Health Technology |
- Beurs
- Insiders
- Ben Vollrath
- Ervaring